Optimizing Skin Delivery of Active Ingredients From Emulsions: From Theory To Practice

Delivery System Handbook for Personal Care and Cosmetic Products

Volumn , Issue , 2005, Pages 409-436

  Wiechers, Johann W ^a  

^a Uniqema Gouda ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882914253     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-081551504-3.50025-0     Document Type: Chapter

References (33)

1. Schaefer H., Redelmeier T.E. Skin Barrier, Principlese of Percutaneous Absorption 1996, Karger, Basel.
2. Bouwstra J.A., Pilgram G., Gooris G.S., Koerten H., Ponce M. New aspects of the skin barrier organization. Skin Pharmacol. Appl. Skin Physiol. 2001, 14:52-62.
3. Potts R.O., Guy R.H. Predicting skin permeability. Pharm. Res. 1992, 9:663-669.
4. Barratt M.D. Quantitative structure-activity relationships for skin permeability. Toxicol. In Vitro 1995, 9:27-37.
5. Franz T.J. Percutaneous absorption. On the relevance of in vitro data. J. Invest. Dermatol. 1975, 54:399-404.
6. Bronaugh R.L., Stewart R.F. Methods for Percutaneous absorption studies. IV The flow-through diffusion cell. J Pharm. Sci. 1985, 74:64-67.
7. Wiechers J.W., unpublished data.
8. Bucks D.A.W., McMaster J.R., Maibach H.I., Guy R.H. Bioavailability of topically administered steroids: A 'mass balance' technique. J. Invest. Dermatol. 1988, 91:29-33.
9. Wiechers J.W. The barrier function of the skin in relation to percutaneous absorption of drugs. Pharm. Wkbl. Sci. Ed. 1989, 11:185-198.
10. Distante F., Rigano L., D'Agostino R., Bonfigh A., Berardesca E. Intra- and inter-individual differences in sensitive skin. Cosmet. & Toilet. 2002, 117(7):39-46.
11. Barry B.W. Dermatological Formulations - Percutaneous Absorption 1983, Marcel Dekker, New York.
12. Cullander C., Guy R.H. Visualising the pathways of iontophoretic current flow in real time with laser-scanning confocal microscopy and the vibrating probe electrode. Prediction of Percutaneous Penetration 1991, 2:229-237. IBC Technical Services Ltd, London. R.C. Scott, R.H. Guy, J. Hadgraft, H.E. Boddé (Eds.).
13. Anderson C. Cutaneous microdialysis. Prediction of Percutaneous Penetration 1998, 6a:16. STS Publishing, Cardiff. K.R. Brain, K.A. Walters (Eds.).
14. Benfeldt E.; In-vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration. Ph.D. thesis, University of Copenhagen, Faculty of Health Sciences, 1999, Acta Dermato-Venereologica, Supplement 206, ISSN 0365-8341.
15. Caspers P.J., Lucassen G.W., Carter E.A., Bruining H.A., Puppels G.J. In vivo confocal Raman microspectroscopy of the skin: Noninvasive determination of molecular concentration profiles. J. Invest. Dermatol. 2001, 116:434-442.
16. Williams A.C., Cornwell P.A., Barry B.W. On the non-Gaussian distribution of human skin permeabilities. Int. J. Pharm. 1992, 86:69-77.
17. Johnson M.E., Blankschtein D., Langer R. Permeation of steroids through human skin. J. Pharm. Sci. 1995, 84:1144-1146.
18. Flynn G.L. Physicochemical determinants of skin absorption. Principles of route to route extrapolation for risk assessment 1990, 93-127. Elsevier, New York. T.R. Gerrity, C.J. Henry (Eds.).
19. Bronaugh R.L., Stewart R.F., Congdon E.L., Giles A.L. Methods for in-vitro percutaneous absorption studies III. Hydrophobic compounds. J. Pharm. Sci. 1984, 73:1255-1257.
20. Ruddy S.B. Surfactants. Percutaneous Penetration Enhancers 1995, 245-258. CRC Press, Boca Raton, FL, USA, Chapter 8.1. E.W. Smith, H.I. Maibach (Eds.).
21. Walters K.A., Walker M., Olejnik O. Non-ionic surfactant effects on hairless mouse skin permeability characteristics. J. Pharm. Pharmacol. 1988, 40:525-529.
22. Sarpotdar P.P., Zatz J.L. Evaluation of penetration enhancement of lidocaine by nonionic surfactants through hairless mouse skin in-vitro. J. Pharm. Sci. 1986, 75:176-181.
23. Wiechers, J.W., Bouwstra, J.A.; Identification of another barrier in human skin: the water barrier. Proceedings of the Annual Scientific Meeting of the Society of Cosmetic Chemists, December 2002, New York, NY, USA.
24. Wiechers J.W., Wortel V.A.L. Making sense of sensory data. Cosmetics & Toiletries 2000, 115(3):37-45.
25. Wiechers J.W., Wortel V.A.L. Bridging the language gap between cosmetic formulators and consumers. Cosmetics & Toiletries 2000, 115(5):33-41.
26. Kumar S., Malick A.W., Meltzer N.M., Mouskountakis J.D., Behl C.R. Studies of in-vitro skin permeation and retention of a leukotriene antagonist from topical vehicles with a hairless guinea pig model. J. Pharm. Sci. 1997, 81:631-634.
27. Wiechers J.W. Formulating for Efficacy. Proceedings of the 2003 IFSCC Conference, Seoul, Korea 2003.
28. Scheuplein R.J., Blank I.H. Mechanism of percutaneous absorption. IV Penetration of non-electrolytes (alcohols) from aqueous solutions and from pure liquids. J. Invest. Dermatol. 1973, 60:286-296.
29. Hansch C., Leo A. Substituent Constants for Correlation Analysis in Chemistry and Biology 1979, J. Wiley & Sons, New York.
30. Bouwstra J.A., De Graaff A., Gooris G.S., Nijsse J., Wiechers J.W., Van Aelst A.C. Water distribution and related morphology in human stratum corneum at different hydration levels. J. Invest. Dermatol. 2003, 120:750-758.
31. Wiechers J.W., Groenhof F.J., Wortel V.A.L., Hindle N.A., Miller R.M. Efficacy studies using octadecenedioic acid, a new nature derived ingredient to even Asian skin tone. SÖFW September 2002, 128:2-8.
32. Wiechers, J.W., Melanosomes, melanocytes and dioic acid, Proceedings of the 37th Annual Conference of the Australian Society of Cosmetic Chemists, "Cosmetics on a New Horizon", 13-16 March 2003, Hamilton Island, Queensland, Australia.
33. Wiechers J.W., Groenhof F.J., Wortel V.A.L., Miller R.M., Hindle N.A., Drewitt-Barlow A. Octadecenedioic Acid for a more even skin tone. Cosmetics & Toiletries July 2002, 117:55-68.